PineBridge Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
14,683
-41,667
-74% -$5.83M 0.02% 309
2025
Q4
$6.92M Sell
56,350
-124,494
-69% -$15.1M 0.05% 213
2025
Q3
$20.1M Sell
180,844
-26,893
-13% -$3.06M 0.15% 131
2025
Q2
$23M Buy
207,737
+22,150
+12% +$2.36M 0.18% 114
2025
Q1
$20.8M Buy
+185,587
New +$19.1M 0.17% 123
2024
Q4
Sell
-71,860
Closed -$6.02M 732
2024
Q3
$6.02M Sell
71,860
-90,286
-56% -$6.89M 0.05% 289
2024
Q2
$11.1M Sell
162,146
-340,872
-68% -$22.7M 0.09% 211
2024
Q1
$36.8M Buy
503,018
+298,743
+146% +$23M 0.29% 71
2023
Q4
$16.5M Sell
204,275
-363,872
-64% -$28.3M 0.15% 154
2023
Q3
$42.6M Buy
568,147
+479,000
+537% +$36.8M 0.47% 44
2023
Q2
$6.87M Buy
89,147
+67,591
+314% +$5.39M 0.07% 232
2023
Q1
$1.79M Sell
21,556
-7,328
-25% -$607K 0.02% 364
2022
Q4
$2.48M Sell
28,884
-44,702
-61% -$3.54M 0.03% 337
2022
Q3
$4.54M Buy
73,586
+53,489
+266% +$3.37M 0.06% 268
2022
Q2
$1.24M Sell
20,097
-98,008
-83% -$6.07M 0.02% 381
2022
Q1
$7.02M Sell
118,105
-58,110
-33% -$3.71M 0.08% 244
2021
Q4
$12.8M Buy
176,215
+174,616
+10,920% +$12M 0.13% 174
2021
Q3
$112K Sell
1,599
-42,378
-96% -$2.98M ﹤0.01% 545
2021
Q2
$3.03M Sell
43,977
-123,760
-74% -$8.26M 0.04% 385
2021
Q1
$10.8M Sell
167,737
-91,485
-35% -$5.9M 0.14% 188
2020
Q4
$15.1M Sell
259,222
-5,356
-2% -$323K 0.23% 105
2020
Q3
$16.7M Buy
264,578
+125,568
+90% +$8.71M 0.29% 84
2020
Q2
$10.7M Buy
139,010
+57,249
+70% +$4.39M 0.2% 126
2020
Q1
$6.11M Sell
81,761
-116,308
-59% -$8.04M 0.14% 178
2019
Q4
$12.9M Sell
198,069
-100,960
-34% -$6.57M 0.2% 128
2019
Q3
$19M Sell
299,029
-11,040
-4% -$722K 0.31% 83
2019
Q2
$20.9M Buy
310,069
+78,782
+34% +$5.18M 0.34% 85
2019
Q1
$15M Buy
231,287
+143,764
+164% +$9.56M 0.3% 92
2018
Q4
$5.47M Buy
87,523
+86,859
+13,081% +$6.07M 0.12% 190
2018
Q3
$51K Sell
664
-141
-18% -$10.6K ﹤0.01% 969
2018
Q2
$57K Sell
805
-484
-38% -$34.2K ﹤0.01% 978
2018
Q1
$97K Buy
+1,289
New +$102K ﹤0.01% 956
2017
Q4
Sell
-905
Closed -$73K 1087
2017
Q3
$73K Buy
+905
New +$69.2K ﹤0.01% 998
2017
Q2
Sell
-13,342
Closed -$906K 1157
2017
Q1
$906K Sell
13,342
-5,972
-31% -$420K 0.02% 532
2016
Q4
$1.38M Sell
19,314
-19,231
-50% -$1.43M 0.04% 318
2016
Q3
$3.05M Sell
38,545
-109,468
-74% -$8.89M 0.14% 173
2016
Q2
$12.3M Sell
148,013
-87,789
-37% -$7.79M 0.63% 47
2016
Q1
$21.7M Sell
235,802
-43,438
-16% -$3.92M 1.11% 16
2015
Q4
$28.3M Sell
279,240
-43,403
-13% -$4.52M 1.22% 14
2015
Q3
$31.7M Sell
322,643
-10,283
-3% -$1.14M 1.35% 10
2015
Q2
$39M Buy
332,926
+109,733
+49% +$12M 1.54% 9
2015
Q1
$21.9M Sell
223,193
-29,407
-12% -$2.99M 0.81% 29
2014
Q4
$23.8M Buy
252,600
+73,039
+41% +$7.55M 0.9% 21
2014
Q3
$19.1M Buy
179,561
+16,041
+10% +$1.57M 0.78% 23
2014
Q2
$13.6M Sell
163,520
-42,614
-21% -$3.32M 0.54% 50
2014
Q1
$14.6M Sell
206,134
-19,099
-8% -$1.5M 0.48% 67
2013
Q4
$16.9M Sell
225,233
-74,049
-25% -$5.16M 0.5% 62
2013
Q3
$18.8M Sell
299,282
-6,967
-2% -$416K 0.58% 49
2013
Q2
$15.7M Buy
+306,249
New +$16M 0.5% 60

Other funds holding GILD

PineBridge Investments's GILD Position: Q1 2026 in Review

PineBridge Investments reduced its Gilead Sciences (GILD) stake by 74% in Q1 2026, selling an estimated $5.83M and leaving 14,683 shares worth $2.05M. The position accounts for 0.02% of the portfolio, ranked #309.

PineBridge Investments first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $42.6M in Q3 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • PineBridge Investments held 14,683 shares of Gilead Sciences worth $2.05M as of Q1 2026.
  • PineBridge Investments sold 41,667 Gilead Sciences shares in Q1 2026, an estimated $5.83M.
  • Gilead Sciences made up 0.02% of PineBridge Investments's portfolio in Q1 2026, its #309 holding.
  • PineBridge Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
  • PineBridge Investments's Gilead Sciences position peaked at $42.6M in Q3 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.